Fate Therapeutics Inc (FATE)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$1.07

Buy

$1.08

arrow-up$0.0298 (+2.84%)

Prices updated at 19 Dec 2025, 14:45 EST

Prices minimum 15 mins delay

Prices in USD

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.

NASDAQ

1.38%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$1.08 - $1.02
	$1.99 - $0.66
	-
	122.85m
	-
	-
	20,904
	0.52
	2,048,375.71
	3.42
	113.93m
	US31189P1021
	-1.33
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.